Fermi is trading at $6.28 (+4.15%) as investors rotate into risk assets during a broad market rebound.
- The move aligns with a stronger session for U.S. equities and a firmer biotech sector, despite no evident company-specific catalysts.
- The stock continues to stabilize after a 5.98% surge on August 3 and significant volatility last week.